Cocrystal Pharma to Present at H.C. Wainwright Virtual BioConnect Conference

Rhea-AI Summary

BOTHELL, Wash., Jan. 5, 2021 – Cocrystal Pharma, Inc. (Nasdaq: COCP) announced that management will present at the H.C. Wainwright Virtual BioConnect Conference from January 11-14, 2021. The presentation will be accessible on the company’s website starting January 11, 2021, at 6:00 a.m. Eastern time. CEO Gary Wilcox highlighted the company's progress in advancing its pipeline of novel antiviral compounds during 2020 and expressed anticipation for discussing upcoming milestones at the conference.

For more details about Cocrystal, visit www.cocrystalpharma.com.

BOTHELL, Wash., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics, announces management will present at the H.C. Wainwright Virtual BioConnect Conference being held January 11-14, 2021. The presentation can be accessed on the IR Calendar section of the Cocrystal website beginning on January 11, 2021 at 6:00 a.m. Eastern time.

“We are pleased with our progress in 2020 in advancing our pipeline of novel antiviral compounds,” said Gary Wilcox, Ph.D., Chairman and Chief Executive Officer of Cocrystal. “We look forward to presenting at this conference and introducing upcoming milestones.”

About Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, hepatitis C viruses, coronaviruses and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.

Investor Contact:
LHA Investor Relations
Jody Cain
310-691-7100
jcain@lhai.com

# # #

FAQ

When is Cocrystal's presentation at the H.C. Wainwright Virtual BioConnect Conference?

Cocrystal's presentation will take place from January 11-14, 2021.

What time will the Cocrystal presentation be available online?

The presentation will be accessible starting January 11, 2021, at 6:00 a.m. Eastern time.

What is the focus of Cocrystal Pharma's research and development?

Cocrystal Pharma focuses on discovering and developing novel antiviral therapeutics targeting influenza, hepatitis C, coronaviruses, and noroviruses.

Who is the CEO of Cocrystal Pharma?

The CEO of Cocrystal Pharma is Gary Wilcox.

Where can I watch the Cocrystal presentation?

The presentation can be watched on the Cocrystal website in the IR Calendar section.